HOWL Werewolf: Korxona qiymati/daromad multiplikatori

Ommaviy kompaniya Werewolf Therapeutics Inc. (HOWL) logotipi

Werewolf Therapeutics kompaniyasining tadqiqot bosqichida ekanligi sababli pul oqimlarining minimal darajada bashorat qilinishi EV/Sales koeffitsiyenti tendentsiyasida yaqqol ko'rinmoqda, bunda parametr 287.62 darajasida mustahkamlandi. Biznes barqarorligi INDUKINE platformasi va sanoat gigantlari bilan hamkorlikka asoslangan. HOWL kapitalizatsiyasi hozirda ichki ishlanmalar sikllariga va saratonga qarshi yangi molekulalarning dastlabki sinovlari natijalariga bog'liq.

Kompaniya qiymatining daromadga nisbati: Werewolf (HOWL) 23.11.2025 - 20.11.2026 uchun

Werewolf - tahliliy kesimlar va asosiy koʻrsatkichlar (HOWL)

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning dastlabki tahlili:Werewolf Therapeutics Inc. HOWL
Werewolf Therapeutics Inc. tovar namunasi

EV/Sales koeffitsiyenti aktivlarning haqiqiy bozor qiymatini ochib berish uchun qarz yuklamasi ta'sirini hisobga olmagan holda, biznes qiymatini yillik daromadga nisbatan o'lchaydi. EV/Sales tarixini tahlil qilish orqali investor 287.62 ning joriy qiymatini ko'radi, bu esa AQShda Werewolf Therapeutics (HOWL) biologik preparatlarining himoyalangan huquqiy maqomi bilan birgalikda, konsolidatsiya chegaralarini belgilashda "qiymat tuzog'i" xavfini minimallashtiradi.

Werewolf Therapeutics raqobatchilari tahlili

IBRX (immunitybio.com) - Kompaniya qiymati va daromad nisbati|Immunocore Corp (IMCR) - Korxona qiymatining daromadga nisbati|Korxona qiymati/daromad multiplikatori Janux Pharma (JANX)|Kompaniya qiymatining daromadga nisbati RCUS|ZYME - Korxona qiymatining sotuvga nisbati|Kompaniya qiymatining daromadga nisbati TNGX (Tango Pharma)|Korxona qiymati/daromad koeffitsiyenti IOVA|EV/Sales multiplikatori IMTX (Immatics)|Biznes qiymatining daromadga nisbati XNCR|compasstherapeutics.com - EV/Sales multiplikatori|Korxona qiymati/daromad multiplikatori Replimune Inc.|Lyell Immunopharma (LYEL) - Korxona qiymatining daromadga nisbati|Innate Pharma S.A. - Biznes qiymatining daromadga nisbati|PYXS (Pyxis) - EV/Sales multiplikatori|EV/Sales multiplikatori cgen.com|Korxona qiymatining daromadga nisbati IO Biotech (IOBT)|STRO: Korxona qiymatining sotish hajmiga nisbati|MiNK Therapeutics Inc. - Kompaniya qiymatining daromadga nisbati|Immix (IMMX) - Korxona qiymati/daromad multiplikatori|ALX Oncology Holdings Inc. - EV/Sales multiplikatori|CUE - EV/Sales multiplikatori|PDSB: EV/Sales multiplikatori|Korxona qiymati/daromad multiplikatori Sonnet BioTherapeutics Holdings Inc. (SONN)|MAIA (MAIABiotech.com) - EV/Sales multiplikatori|Kompaniya qiymatining daromadga nisbati Liminatus Pharma (LIMN)|EV/Sales multiplikatori LVTX|Korxona qiymati/daromad koeffitsiyenti NXTC|Leap Therapeutics, Inc. - Kompaniya qiymatining daromadga nisbati|INTS: Kompaniya qiymati va daromad nisbati|Sensei Biotherapeutics Inc - EV/Sales multiplikatori|TOVX: Korxona qiymatining daromadga nisbati|gritstonebio.com (GRTS) - Korxona qiymatining daromadga nisbati|Kompaniya qiymati va daromad nisbati KA|Korxona qiymatining daromadga nisbati NexImmune, Inc.|Kompaniya qiymati va daromad nisbati TSBX (Turnstone Biologics)|Kompaniya qiymatining daromadga nisbati VCNX (Vaccinex, Inc.)|Korxona qiymati/daromad koeffitsiyenti HARP